05 Mar Bellbrook Labs gets patent for assay platform
Madison, Wis. – BellBrook Labs, a provider of high throughput screening tools for the drug discovery industry, has announced that the U.S. Patent and Trademark Office has issued the company a patent for its Transcreener assay platform.
The product was developed to rapidly screen more new targets, and it provides a generic detection method for multiple enzyme families.
Since introduction of the first Transcreener assays, the platform has been validated and adopted by pharmaceutical and biotechnology screening labs worldwide.
• Grants worth $800,000 help BellBrook Labs develop products
• Bill Shepard: UW biotech program launches graduates into evolving industry (part 2)
• Emerging technology companies receive significant funding
• BellBrook Labs gets major research funding